Literature DB >> 6346918

Determinants of blood acetaldehyde level during ethanol oxidation in chronic alcoholics.

H Nuutinen, K O Lindros, M Salaspuro.   

Abstract

We analyzed the blood alcohol and acetaldehyde concentrations in nine alcoholics and four healthy nonalcoholic controls during and after an intravenous infusion of a high and a low dose of alcohol. In the alcoholics, the mean rates of plasma ethanol disappearance were significantly higher than in nonalcoholic controls. In the control subjects, the blood acetaldehyde levels were, in general, below the detection limit (less than 0.5 microM), but in sharp contrast to this, an elevated blood acetaldehyde during ethanol infusion was found in 6/9 alcoholics. Peak blood acetaldehyde values were higher after the high than the low dose of alcohol. Fructose infusion significantly enhanced the rate of plasma ethanol disappearance both in controls and in alcoholics, and this was usually associated with a significant elevation of blood acetaldehyde level. The maximal specific activities (expressed as milliunits/mg og protein) of alcohol, lactate, and aldehyde dehydrogenases in liver were significantly lower in alcoholics than in controls. Even more importantly, the peak blood acetaldehyde correlated negatively with the activity of hepatic "low-Km" aldehyde dehydrogenase. Our results suggest that the main reason for blood acetaldehyde elevation seen in these chronic alcoholics is their impaired capacity to metabolize acetaldehyde. This may be further accentuated by the increased rate of ethanol oxidation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346918     DOI: 10.1111/j.1530-0277.1983.tb05432.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  27 in total

1.  Free radical generation by neutrophils: a potential mechanism of cellular injury in acute alcoholic hepatitis.

Authors:  A J Williams; R E Barry
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

2.  Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts.

Authors:  Y Israel; E Hurwitz; O Niemelä; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Pancreatic injury in hepatic alcohol dehydrogenase-deficient deer mice after subchronic exposure to ethanol.

Authors:  Bhupendra S Kaphalia; Kamlesh K Bhopale; Shakuntala Kondraganti; Hai Wu; Paul J Boor; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2010-05-15       Impact factor: 4.219

Review 4.  Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Concentration-time profiles of ethanol and acetaldehyde in human volunteers treated with the alcohol-sensitizing drug, calcium carbimide.

Authors:  A W Jones; J Neiman; M Hillbom
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 6.  ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications.

Authors:  Yingmei Zhang; Jun Ren
Journal:  Pharmacol Ther       Date:  2011-06-12       Impact factor: 12.310

7.  Alcohol intake and folate antagonism via CYP2E1 and ALDH1: effects on oral carcinogenesis.

Authors:  Phillip H Hwang; Lisa Lian; Athanasios I Zavras
Journal:  Med Hypotheses       Date:  2011-11-17       Impact factor: 1.538

8.  Alcohol oxidizing enzymes and ethanol-induced cytotoxicity in rat pancreatic acinar AR42J cells.

Authors:  Kamlesh K Bhopale; Miriam Falzon; G A S Ansari; Bhupendra S Kaphalia
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-11-27       Impact factor: 2.416

9.  Hepatic lipid profiling of deer mice fed ethanol using ¹H and ³¹P NMR spectroscopy: a dose-dependent subchronic study.

Authors:  Harshica Fernando; Kamlesh K Bhopale; Paul J Boor; G A Shakeel Ansari; Bhupendra S Kaphalia
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-03       Impact factor: 4.219

10.  Identification of arsenite-and arsenic diglutathione-binding proteins in human hepatocarcinoma cells.

Authors:  Ayano Mizumura; Takayuki Watanabe; Yayoi Kobayashi; Seishiro Hirano
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-27       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.